Current Portfolio
Exciva
Exciva is a German clinical-stage biotech company developing Deraphan, a combination of dextromethorphan and deramciclane, for the treatment of agitation in Alzheimer’s Disease (AD).
Key Facts
- Sector
Life Sciences
- Country
Germany
- Fund
LSP Dementia Fund
- Entry
2025
Website
Responsible Partner
News
Do you want to know more about investing with EQT?
We are eager to explore how we can achieve great things together.